The Beneficial and Adverse Effects of Raloxifene in Menopausal Women: A Mini Review
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The present mini review aimed to summarize the existing knowledge regarding the beneficial and adverse effects of raloxifene in menopausal women. Methods: This study is a review of relevant publications about the effects of raloxifene on sleep disorder, depression, venous thromboembolism, the plasma concentration of lipoprotein, breast cancer, and cognitive function among menopausal women.Results: Raloxifene showed no significant effect on depression and sleep disorder. Verbal memory improved with administration of 60 mg/day of raloxifene while a mild cognitive impairment risk reduction by 33% was observed with administration of 120 mg/ day of raloxifene. Raloxifene was associated with a 50% decrease in the need for prolapse surgery. The result of a meta-analysis showed a significant decline in the plasma concentration of lipoprotein in the raloxifene group compared to placebo (standardized mean difference, -0.43; 10 trials). A network meta-analysis showed that raloxifene significantly decreased the risk of breast cancer (relative risk, 0.572; 95% confidence interval, 0.327-0.881; P = 0.01). In terms of adverse effects of raloxifene, the odds ratio (OR) was observed to be 1.54 (P = 0.006), indicating 54% increase in the risk of deep vein thrombosis (DVT) while the OR for pulmonary embolism (PE) was 1.05, suggesting a 91% increase in the risk of PE alone (P = 0.03). Conclusions: Raloxifene had no significant effect on depression and sleep disorder but decreased the concentration of lipoprotein. Raloxifene administration was associated with an increased risk of DVT and PE and a decreased risk of breast cancer and pelvic organ prolapse in postmenopausal women.
Abstract
Objectives: The present mini review aimed to summarize the existing knowledge regarding the beneficial and adverse effects of raloxifene in menopausal women. Methods: This study is a review of relevant publications about the effects of raloxifene on sleep disorder, depression, venous thromboembolism, the plasma concentration of lipoprotein, breast cancer, and cognitive function among menopausal women.Results: Raloxifene showed no significant effect on depression and sleep disorder. Verbal memory improved with administration of 60 mg/day of raloxifene while a mild cognitive impairment risk reduction by 33% was observed with administration of 120 mg/ day of raloxifene. Raloxifene was associated with a 50% decrease in the need for prolapse surgery. The result of a meta-analysis showed a significant decline in the plasma concentration of lipoprotein in the raloxifene group compared to placebo (standardized mean difference, -0.43; 10 trials). A network meta-analysis showed that raloxifene significantly decreased the risk of breast cancer (relative risk, 0.572; 95% confidence interval, 0.327-0.881; P = 0.01). In terms of adverse effects of raloxifene, the odds ratio (OR) was observed to be 1.54 (P = 0.006), indicating 54% increase in the risk of deep vein thrombosis (DVT) while the OR for pulmonary embolism (PE) was 1.05, suggesting a 91% increase in the risk of PE alone (P = 0.03). Conclusions: Raloxifene had no significant effect on depression and sleep disorder but decreased the concentration of lipoprotein. Raloxifene administration was associated with an increased risk of DVT and PE and a decreased risk of breast cancer and pelvic organ prolapse in postmenopausal women.
참고문헌 (19)
- Barton D, "Hot flashes : aetiology and management", Drugs Aging, 18, pp.597~606 (2001)
- Parisa Parsa, "Effects of Group Counseling on Self-care Behaviors in Menopausal Women with Diabetes", 대한폐경학회지, 23(2), pp.108~116 (2017), 대한폐경학회
- Yousefi Z, "Impacts of herbal medicines on hot flash : A systematic review", J Med Plants, 3, pp.40~46 (2016)
- Stearns V, "Paroxetine controlled release in the treatment of menopausal hot flashes : a randomized controlled trial", JAMA, 289, pp.2827~2834 (2003)
- Ghazanfarpour M, "Effect of Foeniculum vulgare(fennel)on symptoms of depression and anxiety in postmenopausal women : a double-blind randomised controlled trial", J Obstet Gynaecol, 38, pp.121~126 (2018)
- Yang ZD, "Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials", Maturitas, 75, pp.341~348 (2013)
- Young Hwa Cho, "Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density", 대한폐경학회지, 22(3), pp.174~179 (2016), 대한폐경학회
- Blumenthal RS, "Cardiovascular effects of raloxifene : the arterial and venous systems", Am Heart J, 147, pp.783~789 (2004)
- Konyalioglu S, "The potential antioxidant effect of raloxifene treatment: a study on heart, liver and brain cortex of ovariectomized female rats", Cell Biochem Funct, 25, pp.259~266 (2007)
- Ko SS, "Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene", Expert Opin Pharmacother, 12, pp.657~674 (2011)
- Vogel VG, "Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: Preventing breast cancer", Cancer Prev Res (Phila), 3, pp.696~706 (2010)
- 엄미정, "Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women", 대한폐경학회지, 23(1), pp.56~62 (2017), 대한폐경학회
- Walsh BW, "Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women", JAMA, 279, pp.1445~1451 (1998)
- Ferretti G, "Raloxifene lowers plasma lipoprotein(a)concentrations : a systematic review and meta-analysis of randomized placebo-controlled trials", Cardiovasc Drugs Ther, 31, pp.197~208 (2017)
- Mocellin S, "Breast cancer chemoprevention: A network meta-analysis of randomized controlled trials", J Natl Cancer Inst, 108 (2016)
- Ismail SI, "Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women", Cochrane Database Syst Rev, 9, pp.CD007063~ (2010)
- Adomaityte J, "Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis", Thromb Haemost, 99, pp.338~342 (2008)
- Auro K, "A metabolic view on menopause and ageing", Nat Commun, 5, pp.4708~ (2014)
- Woodard GA, "Lipids, menopause, and early atherosclerosis in Study of Women’s Health Across the Nation Heart women", Menopause, 18, pp.376~384 (2011)